MMR - FDA approves Diovan
FDA APPROVES DIOVAN: Novartis Pharmaceuticals Corp. has announced that the Food and Drug Administration has approved Diovan (valsartan) for a new indication to reduce cardiovascular death in patients at high risk following a heart attack. As a result, the drug can now be prescribed in a broader range of heart-failure patients.
Related Results
DiovanDiovanDiovan dosesNew indication for diovanHill Holliday nets Diovan
COPYRIGHT 2005 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
